637 related articles for article (PubMed ID: 30085158)
1. A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment.
Prakash H; Ghosh AK; Rudramurthy SM; Singh P; Xess I; Savio J; Pamidimukkala U; Jillwin J; Varma S; Das A; Panda NK; Singh S; Bal A; Chakrabarti A
Med Mycol; 2019 Jun; 57(4):395-402. PubMed ID: 30085158
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of mucormycosis in north India: experience from a tertiary care hospital.
Bala K; Chander J; Handa U; Punia RS; Attri AK
Med Mycol; 2015 Apr; 53(3):248-57. PubMed ID: 25587084
[TBL] [Abstract][Full Text] [Related]
3. Mucormycosis-A clinicoepidemiological review of cases over 10 years.
Manesh A; Rupali P; Sullivan MO; Mohanraj P; Rupa V; George B; Michael JS
Mycoses; 2019 Apr; 62(4):391-398. PubMed ID: 30685896
[TBL] [Abstract][Full Text] [Related]
4. Diabetes mellitus as the major risk factor for mucormycosis in Mexico: Epidemiology, diagnosis, and outcomes of reported cases.
Corzo-León DE; Chora-Hernández LD; Rodríguez-Zulueta AP; Walsh TJ
Med Mycol; 2018 Jan; 56(1):29-43. PubMed ID: 28431008
[TBL] [Abstract][Full Text] [Related]
5. Mucormycosis in India: unique features.
Chakrabarti A; Singh R
Mycoses; 2014 Dec; 57 Suppl 3():85-90. PubMed ID: 25187095
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India.
Chowdhary A; Kathuria S; Singh PK; Sharma B; Dolatabadi S; Hagen F; Meis JF
Mycoses; 2014 Dec; 57 Suppl 3():97-107. PubMed ID: 25250768
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Mycologic Characteristics of Emerging Mucormycosis Agent Rhizopus homothallicus.
Rudramurthy SM; Singh S; Kanaujia R; Chaudhary H; Muthu V; Panda N; Pandey A; Thakur S; Kaur H; Ghosh A; Agarwal R; Chakrabarti A
Emerg Infect Dis; 2023 Jul; 29(7):1313-1322. PubMed ID: 37347535
[TBL] [Abstract][Full Text] [Related]
8. A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India.
Patel A; Kaur H; Xess I; Michael JS; Savio J; Rudramurthy S; Singh R; Shastri P; Umabala P; Sardana R; Kindo A; Capoor MR; Mohan S; Muthu V; Agarwal R; Chakrabarti A
Clin Microbiol Infect; 2020 Jul; 26(7):944.e9-944.e15. PubMed ID: 31811914
[TBL] [Abstract][Full Text] [Related]
9. Mucormycosis at a tertiary-care center in Mexico. A 35-year retrospective study of 214 cases.
Bonifaz A; Tirado-Sánchez A; Hernández-Medel ML; Araiza J; Kassack JJ; Del Angel-Arenas T; Moisés-Hernández JF; Paredes-Farrera F; Gómez-Apo E; Treviño-Rangel RJ; González GM
Mycoses; 2021 Apr; 64(4):372-380. PubMed ID: 33253454
[TBL] [Abstract][Full Text] [Related]
10. The environmental source of emerging Apophysomyces variabilis infection in India.
Prakash H; Ghosh AK; Rudramurthy SM; Paul RA; Gupta S; Negi V; Chakrabarti A
Med Mycol; 2016 Aug; 54(6):567-75. PubMed ID: 27118802
[TBL] [Abstract][Full Text] [Related]
11. Mucormycosis due to Apophysomyces species complex- 25 years' experience at a tertiary care hospital in southern India.
Pamidimukkala U; Sudhaharan S; Kancharla A; Vemu L; Challa S; Karanam SD; Chavali P; Prakash H; Ghosh AK; Gupta S; Rudramurthy SM; Chakrabarti A
Med Mycol; 2020 Jun; 58(4):425-433. PubMed ID: 31342074
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of Mucormycosis in India.
Prakash H; Chakrabarti A
Microorganisms; 2021 Mar; 9(3):. PubMed ID: 33806386
[TBL] [Abstract][Full Text] [Related]
13. Mucormycosis caused by Apophysomyces species: An experience from a tertiary care hospital in Western India and systematic review of global cases.
Samaddar A; Shrimali T; Sharma A
Mycoses; 2023 Mar; 66(3):181-195. PubMed ID: 36227645
[TBL] [Abstract][Full Text] [Related]
14. Mucormycosis in Iran: A six-year retrospective experience.
Dolatabadi S; Ahmadi B; Rezaei-Matehkolaei A; Zarrinfar H; Skiada A; Mirhendi H; Nashibi R; Niknejad F; Nazeri M; Rafiei A; Gharaghani M; Erami M; Taghipour S; Piri F; Makimura K
J Mycol Med; 2018 Jun; 28(2):269-273. PubMed ID: 29545123
[TBL] [Abstract][Full Text] [Related]
15. Emerging Rhizopus microsporus Infections in India.
Pandey M; Singh G; Agarwal R; Dabas Y; Jyotsna VP; Kumar R; Xess I
J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29563203
[No Abstract] [Full Text] [Related]
16. Mucormycosis in Australia: contemporary epidemiology and outcomes.
Kennedy KJ; Daveson K; Slavin MA; van Hal SJ; Sorrell TC; Lee A; Marriott DJ; Chapman B; Halliday CL; Hajkowicz K; Athan E; Bak N; Cheong E; Heath CH; Morrissey CO; Kidd S; Beresford R; Blyth C; Korman TM; Robinson JO; Meyer W; Chen SC;
Clin Microbiol Infect; 2016 Sep; 22(9):775-781. PubMed ID: 26806139
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal mucormycosis in apparently immunocompetent hosts-A review.
Kaur H; Ghosh A; Rudramurthy SM; Chakrabarti A
Mycoses; 2018 Dec; 61(12):898-908. PubMed ID: 29855116
[TBL] [Abstract][Full Text] [Related]
18. Genetic diversity of clinical and environmental Mucorales isolates obtained from an investigation of mucormycosis cases among solid organ transplant recipients.
Nguyen MH; Kaul D; Muto C; Cheng SJ; Richter RA; Bruno VM; Liu G; Beyhan S; Sundermann AJ; Mounaud S; Pasculle AW; Nierman WC; Driscoll E; Cumbie R; Clancy CJ; Dupont CL
Microb Genom; 2020 Dec; 6(12):. PubMed ID: 33245689
[TBL] [Abstract][Full Text] [Related]
19. Mucormycosis in Iran: a systematic review.
Vaezi A; Moazeni M; Rahimi MT; de Hoog S; Badali H
Mycoses; 2016 Jul; 59(7):402-15. PubMed ID: 26906121
[TBL] [Abstract][Full Text] [Related]
20. Fungal necrotizing fasciitis, an emerging infectious disease caused by Apophysomyces (Mucorales).
Chander J; Stchigel AM; Alastruey-Izquierdo A; Jayant M; Bala K; Rani H; Handa U; Punia RS; Dalal U; Attri AK; Monzon A; Cano-Lira JF; Guarro J
Rev Iberoam Micol; 2015; 32(2):93-8. PubMed ID: 25576377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
